Literature DB >> 16532281

[Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

K Reinhart1, F Brunkhorst, H Bone, H Gerlach, M Gründling, G Kreymann, P Kujath, G Marggraf, K Mayer, A Meier-Hellmann, C Peckelsen, C Putensen, M Quintel, M Ragaller, R Rossaint, F Stüber, N Weiler, T Welte, K Werdan.   

Abstract

A recent survey conducted by the publicly funded Competence Network Sepsis (SepNet) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approximately 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approximately 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organization of the German health care system. Priority was given to the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy. The guidelines development process was carefully planned and strictly adhered to the requirements of the Working Group of Scientific Medical Societies (AWMF).

Entities:  

Mesh:

Year:  2006        PMID: 16532281     DOI: 10.1007/s00108-006-1595-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  292 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing.

Authors:  James A Catton; Brian M Dobbins; Peter Kite; Jonathan M Wood; Kerrie Eastwood; Sarah Sugden; Jonathon A T Sandoe; Dermot Burke; Michael J McMahon; Mark H Wilcox
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

3.  Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill.

Authors:  J C Stothert; D A Simonowitz; E P Dellinger; M Farley; W A Edwards; A D Blair; R Cutler; C J Carrico
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

4.  Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.

Authors:  D A Schiappa; M K Hayden; M G Matushek; F N Hashemi; J Sullivan; K Y Smith; D Miyashiro; J P Quinn; R A Weinstein; G M Trenholme
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 5.  Human albumin solution for resuscitation and volume expansion in critically ill patients.

Authors:  P Alderson; F Bunn; C Lefebvre; Wan Po A Li; L Li; I Roberts; G Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2002

6.  Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.

Authors:  Philippe Cestac; Haleh Bagheri; Maryse Lapeyre-Mestre; Pierre Sié; Atoussa Fouladi; Eric Maupas; Philippe Léger; Bernard Fontan; Patrice Massip; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection.

Authors:  R Winter; H Humphreys; A Pick; A P MacGowan; S M Willatts; D C Speller
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

8.  Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Authors:  Marin H Kollef; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2004-01-09       Impact factor: 17.440

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996.

Authors:  M Crowe; P Ispahani; H Humphreys; T Kelley; R Winter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

View more
  9 in total

Review 1.  [Urosepsis and treatment].

Authors:  F M E Wagenlehner; C Lichtenstern; M A Weigand; W Weidner
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

2.  [Sepsis and heart].

Authors:  H Ebelt; K Werdan
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

3.  [Perioperative fluid and volume management. Goal-directed therapy necessary!].

Authors:  A E Goetz; K Heckel
Journal:  Anaesthesist       Date:  2007-08       Impact factor: 1.041

Review 4.  [Diagnosis and causal treatment of sepsis].

Authors:  F M Brunkhorst; K Reinhart
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

Review 5.  [Burn trauma--Part 2. Anesthesiological, surgical and intensive care management].

Authors:  G A Giessler; T Mayer; T Trupkovic
Journal:  Anaesthesist       Date:  2009-05       Impact factor: 1.041

6.  5 Human Albumin.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 7.  [Glycemic control in sepsis and septic shock: friend or foe?].

Authors:  B Ellger; M Westphal; H D Stubbe; I Van den Heuvel; H Van Aken; G Van den Berghe
Journal:  Anaesthesist       Date:  2008-01       Impact factor: 1.041

Review 8.  [Supportive and adjunctive sepsis therapy].

Authors:  F M Brunkhorst; K Reinhart
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

9.  The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.

Authors:  Reiner M Waeschle; Onnen Moerer; Reinhard Hilgers; Peter Herrmann; Peter Neumann; Michael Quintel
Journal:  Crit Care       Date:  2008-10-21       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.